These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8031607

  • 21. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G.
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [Abstract] [Full Text] [Related]

  • 22. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 23. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
    Murray PG, Niedobitek G, Kremmer E, Grässer F, Reynolds GM, Cruchley A, Williams DM, Müller-Lantzsch N, Young LS.
    J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
    [Abstract] [Full Text] [Related]

  • 24. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
    Dutta N, Gupta A, Mazumder DN, Banerjee S.
    Cancer; 2006 Apr 15; 106(8):1685-93. PubMed ID: 16541432
    [Abstract] [Full Text] [Related]

  • 25. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
    Liu W, Han HX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 15; 26(1):94-7. PubMed ID: 16495186
    [Abstract] [Full Text] [Related]

  • 26. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY, Huang YT, Sheen TS, Chen JY, Tsai CH.
    J Med Virol; 2004 Aug 15; 73(4):574-82. PubMed ID: 15221902
    [Abstract] [Full Text] [Related]

  • 27. Detection of Epstein-Barr virus-associated antigen in fine needle aspiration smears from cervical lymph nodes in the diagnosis of nasopharyngeal carcinoma.
    Chan MK, Huang DW, Ho YH, Lee JC.
    Acta Cytol; 1989 Aug 15; 33(3):351-4. PubMed ID: 2543173
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Aug 15; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 29. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
    Beck A, Päzolt D, Grabenbauer GG, Nicholls JM, Herbst H, Young LS, Niedobitek G.
    J Pathol; 2001 Jun 15; 194(2):145-51. PubMed ID: 11400141
    [Abstract] [Full Text] [Related]

  • 30. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
    Takimoto T, Kamide M, Umeda R.
    Arch Otorhinolaryngol; 1984 Jun 15; 239(1):87-92. PubMed ID: 6318711
    [Abstract] [Full Text] [Related]

  • 31. [In vitro induced and expanded Epstein Barr virus-specific cytotoxic T lymphocytes can specifically kill nasopharyngeal carcinoma cells].
    Chen LP, Huang JQ, Zhou TC, Zhang SX, Wang JL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 15; 28(8):1431-3. PubMed ID: 18753079
    [Abstract] [Full Text] [Related]

  • 32. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
    Micheau C, De The G, Schwaab G, Tursz T, Sancho-Garnier H, Montagu B.
    Ann Pathol; 1984 Aug 15; 4(2):143-6. PubMed ID: 6329239
    [Abstract] [Full Text] [Related]

  • 33. [Change and effect of Epstein Barr virus (EBV) antigen induced T8 cells in nasopharyngeal carcinoma patients and EBV seropositive individuals].
    Huang PC.
    Zhonghua Zhong Liu Za Zhi; 1993 Jan 15; 15(1):12-6. PubMed ID: 8392927
    [Abstract] [Full Text] [Related]

  • 34. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T, Ogura H, Ohno S, Umeda R, Hatano M.
    J Natl Cancer Inst; 1984 Sep 15; 73(3):711-5. PubMed ID: 6088881
    [Abstract] [Full Text] [Related]

  • 35. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G, Decaussin G, Zeng Y, Djennaoui D, Melouli H, Broully P, Bouguermouh AM, Ooka T.
    J Clin Virol; 2005 Sep 15; 34(1):26-34. PubMed ID: 16087121
    [Abstract] [Full Text] [Related]

  • 36. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
    Lu J, Chua HH, Chen SY, Chen JY, Tsai CH.
    Cancer Res; 2003 Jan 01; 63(1):256-62. PubMed ID: 12517806
    [Abstract] [Full Text] [Related]

  • 37. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J, Pai S, Cotter M, Robertson ES.
    Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337
    [Abstract] [Full Text] [Related]

  • 38. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquère S, Nishi N, Hirashima M, Middeldorp J, Busson P.
    BMC Cancer; 2006 Dec 08; 6():283. PubMed ID: 17156439
    [Abstract] [Full Text] [Related]

  • 39. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J, Kremmer E, Meseda CA, Mackett M, Hahn P, Gulley ML, Brink A, Swinnen LJ, Greenspan J, De Souza Y, Grässer F, Sham J, Ng MH, Arrand JR.
    J Med Virol; 2001 Sep 08; 65(1):105-13. PubMed ID: 11505451
    [Abstract] [Full Text] [Related]

  • 40. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B, Chen XY.
    Ai Zheng; 2004 May 08; 23(5):512-6. PubMed ID: 15142445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.